These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21150215)

  • 1. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-to-advanced CKD.
    Kovesdy CP; Molnar MZ; Czira ME; Rudas A; Ujszaszi A; Sarvary E; Ambrus C; Szathmari M; Remport A; Mucsi I
    Nephron Clin Pract; 2011; 118(2):c78-85. PubMed ID: 21150215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKD patients: the dilemma of serum PTH levels.
    Pontoriero G; Cozzolino M; Locatelli F; Brancaccio D
    Nephron Clin Pract; 2010; 116(4):c263-8. PubMed ID: 20639672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?
    Jiménez Alvaro S; Marcén R; Teruel JL; Fernández Rodríguez A; Pascual J; Galeano C; Villacorta J; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2409-11. PubMed ID: 19715935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of chronic kidney disease classification (K/DOQI) in renal transplant patients.
    Fernandez-Fresnedo G; de Francisco A; Ruiz JC; Cotorruelo JG; Alamillo CG; Valero R; Castañeda O; Zalduendo B; Izquierdo MJ; Arias M
    Transplant Proc; 2006 Oct; 38(8):2402-3. PubMed ID: 17097948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
    Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of hyperparathyroidism in advanced stages of chronic kidney disease.
    El Kossi M; Rana A; El Nahas M
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):623-7. PubMed ID: 19587504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
    Inaba M; Nagasue K; Okuno S; Ueda M; Kumeda Y; Imanishi Y; Shoji T; Ishimura E; Ohta T; Nakatani T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Jun; 39(6):1261-9. PubMed ID: 12046040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of serum parathyroid hormone level to severity of heart failure.
    Altay H; Zorlu A; Binici S; Bilgi M; Yilmaz MB; Colkesen Y; Erol T; Muderrisoglu H
    Am J Cardiol; 2012 Jan; 109(2):252-6. PubMed ID: 21996143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.
    Saab G; Whaley-Connell A; McFarlane SI; Li S; Chen SC; Sowers JR; McCullough PA; Bakris GL;
    Metabolism; 2010 Mar; 59(3):385-9. PubMed ID: 19800639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
    Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
    Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.